| scholarly article | Q13442814 |
| P50 | author | Karl-Johan Malmberg | Q56839940 |
| P2093 | author name string | Rolf Kiessling | |
| Helena Harlin | |||
| Isabel Poschke | |||
| C Christian Johansson | |||
| Daiju Sakurai | |||
| Håkan Norell | |||
| Mikael Hanson | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reactive oxygen species | Q424361 |
| P304 | page(s) | 4513-4519 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset | |
| P478 | volume | 179 |
| Q37662204 | A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia |
| Q39011291 | Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts. |
| Q30841600 | Bystander cells enhance NK cytotoxic efficiency by reducing search time |
| Q37882478 | Camouflage and sabotage: tumor escape from the immune system |
| Q38811497 | Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity. |
| Q34387837 | Comparative expression profiling of distinct T cell subsets undergoing oxidative stress |
| Q48015285 | Contribution of alloantigens to hepatic ischemia/reperfusion injury: Roles of natural killer cells and innate immune recognition of nonself |
| Q39549075 | Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material |
| Q53228298 | H₂O₂ production within tumor microenvironment inversely correlated with infiltration of CD56(dim) NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. |
| Q81480997 | Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus |
| Q37620061 | Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells |
| Q37564774 | Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation |
| Q36693111 | Metabolism pathways in chronic lymphocytic leukemia |
| Q92794916 | Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects |
| Q35309120 | Natural killer cells in patients with severe chronic fatigue syndrome. |
| Q38641180 | Oxidative Stress: Placenta Function and Dysfunction |
| Q37548947 | Oxidative stress and lymphocyte persistence: implications in immunotherapy |
| Q38869334 | Polymorphonuclear neutrophils and granulocytic myeloid-derived suppressor cells inhibit natural killer cell activity toward Aspergillus fumigatus |
| Q50249435 | Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease. |
| Q38101671 | Reactive oxygen species in the immune system |
| Q35040765 | Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer. |
| Q35107809 | Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes. |
| Q38067641 | Shaping of NK cell responses by the tumor microenvironment |
| Q43608830 | TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells |
| Q37777529 | The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. |
| Q37638179 | The natural killer cell: a further innate mediator of gouty inflammation? |
| Q56942092 | The yin-yang of the interaction between myelomonocytic cells and NK cells |
| Q38478878 | Therapeutic potential and challenges of natural killer cells in treatment of solid tumors |
| Q38193589 | Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. |
| Q26745898 | Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment |
| Q38715422 | Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress. |
| Q98465701 | cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies |
Search more.